IL107387A - Combination pediatric vaccine with enhanced immunogenicity of each vaccine component - Google Patents

Combination pediatric vaccine with enhanced immunogenicity of each vaccine component

Info

Publication number
IL107387A
IL107387A IL107387A IL10738793A IL107387A IL 107387 A IL107387 A IL 107387A IL 107387 A IL107387 A IL 107387A IL 10738793 A IL10738793 A IL 10738793A IL 107387 A IL107387 A IL 107387A
Authority
IL
Israel
Prior art keywords
vaccine
enhanced immunogenicity
component
tetanus
diphtheria
Prior art date
Application number
IL107387A
Other languages
English (en)
Other versions
IL107387A0 (en
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of IL107387A0 publication Critical patent/IL107387A0/xx
Publication of IL107387A publication Critical patent/IL107387A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Peptides Or Proteins (AREA)
IL107387A 1992-10-27 1993-10-25 Combination pediatric vaccine with enhanced immunogenicity of each vaccine component IL107387A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US96699592A 1992-10-27 1992-10-27

Publications (2)

Publication Number Publication Date
IL107387A0 IL107387A0 (en) 1994-01-25
IL107387A true IL107387A (en) 1997-04-15

Family

ID=25512167

Family Applications (1)

Application Number Title Priority Date Filing Date
IL107387A IL107387A (en) 1992-10-27 1993-10-25 Combination pediatric vaccine with enhanced immunogenicity of each vaccine component

Country Status (22)

Country Link
EP (1) EP0594950B1 (pl)
JP (1) JPH07300427A (pl)
KR (1) KR100289224B1 (pl)
AT (1) ATE176157T1 (pl)
AU (1) AU669570B2 (pl)
CA (1) CA2109159A1 (pl)
CZ (1) CZ283587B6 (pl)
DE (2) DE69323264T4 (pl)
DK (1) DK0594950T3 (pl)
ES (1) ES2126616T3 (pl)
FI (1) FI934725L (pl)
GR (1) GR3029884T3 (pl)
HU (1) HU215149B (pl)
IL (1) IL107387A (pl)
LV (1) LV12271B (pl)
NO (1) NO308588B1 (pl)
NZ (1) NZ250029A (pl)
PL (1) PL174130B1 (pl)
RU (1) RU2121365C1 (pl)
SG (1) SG47725A1 (pl)
TW (1) TW256774B (pl)
UA (1) UA27754C2 (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1864195A (en) * 1994-03-07 1995-09-25 Auckland Uniservices Limited Prevention of diabetes
DE69615362T3 (de) * 1995-06-07 2006-07-20 Smithkline Beecham Biologicals S.A. Impfstoff mit einem polysaccharidantigen-trägerprotein-konjugat und einem trägerprotein
US20020054884A1 (en) 1995-06-23 2002-05-09 Smithkline Beecham Biologicals, Sa Vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate
JP4850987B2 (ja) * 1995-06-23 2012-01-11 グラクソスミスクライン・バイオロジカルス・ソシエテ・アノニム リン酸アルミニウム上に吸着したポリサッカライド結合抗原を含むワクチン組成物
RO120819B1 (ro) * 1996-07-02 2006-08-30 Connaught Laboratories Limited Vaccinuri dtp multivalente
EP2277541A1 (en) * 2000-06-29 2011-01-26 SmithKline Beecham Biologicals S.A. Multivalent vaccine composition
GB0108364D0 (en) 2001-04-03 2001-05-23 Glaxosmithkline Biolog Sa Vaccine composition
RU2175557C1 (ru) * 2000-09-04 2001-11-10 Волков Александр Григорьевич Способ предупреждения воспалительных заболеваний верхних дыхательных путей
EP1409013B1 (en) * 2001-07-26 2009-11-18 Novartis Vaccines and Diagnostics S.r.l. Vaccines comprising aluminium adjuvants and histidine
SI1556477T1 (sl) 2002-11-01 2017-12-29 Glaxosmithkline Biologicals S.A. Sušilni postopek
RU2231793C1 (ru) * 2003-03-11 2004-06-27 Москаленко Екатерина Петровна Способ оценки иммуногенности коклюшных вакцин
RU2244548C1 (ru) * 2003-07-17 2005-01-20 Оренбургская государственная медицинская академия (ОГМА) Средство, повышающее иммуногенные свойства столбнячного анатоксина
RU2274474C1 (ru) * 2004-10-12 2006-04-20 Государственное образовательное учреждение ВПО Красноярская государственная медицинская академия Министерства здравоохранения РФ Способ вакцинации детей против краснухи на крайнем севере
GB0505996D0 (en) * 2005-03-23 2005-04-27 Glaxosmithkline Biolog Sa Fermentation process
WO2007000341A2 (en) 2005-06-27 2007-01-04 Glaxosmithkline Biologicals S.A. Immunogenic composition
RU2303459C1 (ru) * 2005-12-05 2007-07-27 ГУ научно-исследовательский институт медицинских проблем Севера СО РАМН (РФ) Способ вакцинации детей против краснухи на крайнем севере
RU2299744C1 (ru) * 2006-03-02 2007-05-27 ГОУ ВПО "Красноярская государственная медицинская академия Федерального агентства по здравоохранению и социальному развитию" Способ сезонной ревакцинации детей против краснухи на крайнем севере

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ188211A (en) * 1977-10-28 1984-09-28 American Cyanamid Co Isolation of polyribosyl ribitol phosphate(prp)from haemophilus influenzae type b;vaccine comprising prp and bordetellapertussis antigens
US4673574A (en) * 1981-08-31 1987-06-16 Anderson Porter W Immunogenic conjugates
US4902506A (en) * 1983-07-05 1990-02-20 The University Of Rochester Immunogenic conjugates
CA1209036A (en) * 1982-08-20 1986-08-05 Joseph S.C. Kuo Combined haemophilus influenzae and diphtheria, pertussis, tetanus vaccine
HU188847B (en) * 1983-02-22 1986-05-28 Human Oltoanyagtermeloe Es Kutato Intezet,Hu Process for producing liophylized combined vaccines
US4761283A (en) * 1983-07-05 1988-08-02 The University Of Rochester Immunogenic conjugates
DK163176C (da) * 1985-09-27 1992-06-22 Schweiz Serum & Impfinst Ugiftig konjugatvaccine mod infektioner af pseudomonas aeruginosa- og escherichia coli- bakterier, fremgangsmaade til fremstilling heraf og anvendelse af vaccinen

Also Published As

Publication number Publication date
HU215149B (hu) 2000-03-28
IL107387A0 (en) 1994-01-25
TW256774B (pl) 1995-09-11
JPH07300427A (ja) 1995-11-14
HUT67239A (en) 1995-03-28
LV12271A (lv) 1999-05-20
CA2109159A1 (en) 1994-04-28
HK1009931A1 (en) 1999-06-11
EP0594950B1 (en) 1999-01-27
NO308588B1 (no) 2000-10-02
PL174130B1 (pl) 1998-06-30
AU669570B2 (en) 1996-06-13
GR3029884T3 (en) 1999-07-30
KR100289224B1 (ko) 2001-05-02
DE69323264T4 (de) 1999-10-14
AU5029093A (en) 1994-05-12
FI934725A7 (fi) 1994-04-28
UA27754C2 (uk) 2000-10-16
LV12271B (en) 1999-07-20
DE69323264D1 (de) 1999-03-11
RU2121365C1 (ru) 1998-11-10
EP0594950A1 (en) 1994-05-04
NO933856L (no) 1994-04-28
DK0594950T3 (da) 1999-09-13
FI934725A0 (fi) 1993-10-26
FI934725L (fi) 1994-04-28
NZ250029A (en) 1994-09-27
SG47725A1 (en) 1998-04-17
ES2126616T3 (es) 1999-04-01
KR940008698A (ko) 1994-05-16
HU9303028D0 (en) 1994-01-28
CZ283587B6 (cs) 1998-05-13
CZ227293A3 (en) 1994-05-18
ATE176157T1 (de) 1999-02-15
NO933856D0 (no) 1993-10-26
DE69323264T2 (de) 1999-06-02

Similar Documents

Publication Publication Date Title
IL107387A (en) Combination pediatric vaccine with enhanced immunogenicity of each vaccine component
AU696338B2 (en) A vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate
GR3035081T3 (en) Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections
BR9710460A (pt) Composi-Æo imunolÄgica multi-valente e seu uso em vacinas
RU2004136295A (ru) Комбинированные вакцины против бактериального менингита для введения через слизистую оболочку
HU913103D0 (en) Method for producing vaccines of oligosacharide conjugates
Alexander et al. Development of experimental carbohydrate-conjugate vaccines composed of Streptococcus pneumoniae capsular polysaccharides and the universal helper T-lymphocyte epitope (PADRE®)
IE840197L (en) Polysaccharide protein conjugate vaccine
JPH04230634A (ja) 複合ワクチンのキヤリヤー分子としての、百日咳菌の繊維状赤血球凝集素
GR3034916T3 (en) Group a streptococcal polysaccharide immunogenic compositions and methods
RU93048161A (ru) Комбинированная педиатрическая вакцина с усиленной иммуногенностью каждого вакционного компонента
DE69713089T2 (de) Verfahren zur herstellung von immunoaktiven mittel und impfstoffe
CA2133108A1 (en) Pasteurella haemolytica type a-1 bacterin-toxoid vaccine
Michon et al. Combination conjugate vaccines against multiple serotypes of group B streptococci
Isaacs Haemophilus influenzae type b immunization
Guo et al. Studies on meningococcal polysaccharide-tetanus toxoid conjugates.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
RH1 Patent not in force